Esperion Therapeutics
ESPR
A$2.26
Share price
-7.55%
Change (1 day)
-37.21%
Change (1 year)
Categories
EPS for Esperion Therapeutics (ESPR)
EPS in 2025 (TTM): A-$1.22
According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.23. In 2024 the company made an earnings per share (EPS) of A-$0.35 an increase over its 2023 EPS that were of A-$3.25.
EPS history for Esperion Therapeutics from 2014 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | A-$1.22 | 246.96% |
| 2024 | A-$0.35 | -89.15% |
| 2023 | A-$3.25 | -40.28% |
| 2022 | A-$5.45 | -62.87% |
| 2021 | A-$14.67 | 80.38% |
| 2020 | A-$8.13 | 50.14% |
| 2019 | A-$5.42 | -53.18% |
| 2018 | A-$11.57 | 7.41% |
| 2017 | A-$10.77 | 110.81% |
| 2016 | A-$5.11 | 47.35% |
| 2015 | A-$3.47 | 0.89% |
| 2014 | A-$3.44 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Ultragenyx Pharmaceutical RARE | A-$9.02 | 635.00% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | A$4.22 | -443.75% | 🇺🇸 USA |
 Pfizer PFE | A$2.13 | -273.75% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | A$64.08 | -5,320.00% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | A-$0.46 | -62.50% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | A-$0.78 | -36.25% | 🇺🇸 USA |